GCC & Oman
Bringing AI-Assisted Neurosurgery to Oman and the GCC
334 Aqua Med Soft is exploring Oman as its regional base for clinical validation and local manufacturing — aligned with Oman Vision 2040 and the Ministry of Health’s localization goals.
Why Oman?
A Country Investing Decisively in the Future of Healthcare
Oman is investing decisively in the future of healthcare. The Ministry of Health has set a national goal to raise locally manufactured health products from 9% to 30% of the market, and the Future Fund Oman has dedicated a RO 50 million healthcare investment fund to services, medical technology and digital health.
For a company like ours — AI for neurosurgery, clinically validated and commercially proven — this is a natural home in the Gulf.
- 30% localization goal — the Ministry of Health aims to raise locally manufactured health products from 9% to 30% of the market
- RO 50 million healthcare fund — the Future Fund Oman’s dedicated investment vehicle for services, medical technology and digital health
- Oman Vision 2040 — a national strategy built around economic diversification and a modern healthcare sector

Sultan Qaboos Grand Mosque, Muscat — photo: Mostafameraji / Wikimedia Commons, CC BY-SA 4.0
What We Bring
A Clinically Validated Platform, Ready for the Gulf
Brain-Hemorrhage Detection
ICH detection from CT scans at 95% accuracy, trained on approximately 900,000 medical images — integrated into a national neurosurgery training curriculum for emergency triage.
Post-Radiotherapy Tumor Tracking
Automated analysis of sequential patient images to evaluate treatment efficacy — supporting surgeons and radiotherapists in adjusting therapy plans.
LLM Surgical Assistant
Real-time answers over medical documents, literature and training material — faster, more reliable decision-making in complex surgical situations.
Clinically Validated & Commercially Proven
Official efficacy approval from a national health ministry, first commercial sale completed, and ISO 13485 certification in progress with Canadian consultants.
What We’re Looking For
Partners for a Regional Launch
- Clinical partners — Omani hospitals for a neurosurgery / emergency-department pilot
- Manufacturing partners — local assembly aligned with the MoH’s 30% localization goal
- Investors — to fund ISO certification completion, the Canadian regulatory roadmap and GCC expansion
FAQ
Frequently Asked Questions
Is the product clinically validated?
Yes. The system holds official efficacy approval from a national health ministry and is part of a national neurosurgery training curriculum.
What accuracy does your ICH detection achieve?
95% accuracy, trained on a dataset of approximately 900,000 medical images.
Where is the company based?
334 Aqua Med Soft Inc. is incorporated in Winnipeg, Manitoba, Canada. Our team operates internationally.
What regulatory certifications are in progress?
ISO 13485 certification is in progress with Canadian consultants, alongside a Canadian regulatory roadmap (Health Canada medical device licensing).
Interested in a Pilot, Partnership or Investment in the GCC?
We respond to every inquiry personally.
